» Articles » PMID: 31321294

Potential of Membranes Surrounding the Fetus As Immunoprotective Cell-Carriers for Allogeneic Transplantations

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2019 Jul 20
PMID 31321294
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Membranes surrounding the fetus play a crucial role in providing a physical and immunological barrier between a semiallogeneic fetus and mother during pregnancy. In this study, we tested whether cotransplantation of fetal membranes (FMs) and allogeneic donor cells would improve the retention and function of allografts in mice.

Methods: Intact and enzyme-digested membranes obtained from E18-E19 pregnant mice were subcutaneously cotransplanted with 10F7MN hybridoma cells that are of BALB/cByJ (Balb) origin and secrete anti-human CD235a antibody. Cells were transplanted into C57BL/6J (B6, allogeneic), Balb (syngeneic), and FVB/NJ (third-party) mice. Serum was collected after 1 and 3 weeks of cell transplantation and tested using flow cytometry for the presence of anti-human CD235a antibody. Immunosuppressive functions of membranes were further investigated by analyzing the cytokine profile of supernatants collected from allo-reactive mixed lymphocyte reactions (MLRs) using a multiplex cytokine assay.

Results: B6 mice transplanted with 10F7MN cells along with membranes syngeneic to the host had significantly higher levels of CD235a antibody when compared to B6 mice that received cells without membranes, allogenic membranes, or third-party membranes. Syngeneic membranes significantly inhibited T-cell proliferation in the presence of allogeneic stimuli and suppressed the release of Th1-cytokines such as IFNγ, TNFα, and IL-2 in MLRs. Additionally, increases in the levels of Th2-cytokines were found in MLRs containing membrane-derived cells.

Conclusions: Our study highlights the potential use of syngeneic FMs to act as potent cell-carriers that could improve graft retention as well as graft-specific immunoprotection during allograft transplantation.

Citing Articles

Placental Tissues as Biomaterials in Regenerative Medicine.

Roy A, Mantay M, Brannan C, Griffiths S Biomed Res Int. 2022; 2022:6751456.

PMID: 35496035 PMC: 9050314. DOI: 10.1155/2022/6751456.

References
1.
Matthews J, Wnek G, Simpson D, Bowlin G . Electrospinning of collagen nanofibers. Biomacromolecules. 2002; 3(2):232-8. DOI: 10.1021/bm015533u. View

2.
Chen J, Chang M, Muench M . A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. J Immunol Methods. 2003; 279(1-2):123-33. DOI: 10.1016/s0022-1759(03)00236-9. View

3.
Hofmann M, Wollert K, Meyer G, Menke A, Arseniev L, Hertenstein B . Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111(17):2198-202. DOI: 10.1161/01.CIR.0000163546.27639.AA. View

4.
Desai T, Chu W, Rasi G, Sinibaldi-Vallebona P, Guarino E, Ferrari M . Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed Microdevices. 2005; 1(2):131-8. DOI: 10.1023/A:1009948524686. View

5.
Oyen M, Calvin S, Landers D . Premature rupture of the fetal membranes: is the amnion the major determinant?. Am J Obstet Gynecol. 2006; 195(2):510-5. DOI: 10.1016/j.ajog.2006.02.010. View